Studies
Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder
Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder
Request Access
Overview
Selected Publications (4)
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
Joseph P. Schacht, P. Randall, P. Latham, et al.. (2017). Neuropsychopharmacology. Cited 78 times.
https://doi.org/10.1038/npp.2017.74
Nicotine‐Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence
R. Anton, P. Latham, K. Voronin, et al.. (2018). Alcoholism: Clinical and Experimental Research. Cited 23 times.
https://doi.org/10.1111/acer.13601
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
R. Anton, K. Voronin, S. Book, et al.. (2020). Alcoholism, clinical and experimental research. Cited 10 times.
https://doi.org/10.1111/acer.14431
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: A randomized trial
Joseph P. Schacht, Michaela Hoffman, Brian H. Chen, et al.. (2021). The pharmacogenomics journal. Cited 6 times.
https://doi.org/10.1038/s41397-021-00250-8
